Referred TestsDiscover the differences.
Providing more than just results.
Therapeutics testing covers a wide-range of areas from controlled substance monitoring to pharmacogenomics (PGx). We provide access to Mayo Clinic experts and a test menu developed through evidence-driven clinical innovation to help clinicians guide patient care.
Discover how the smallest differences can have the greatest impact. Let's find the right answers together.
By the numbers
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
190+
laboratory tests developed for our specialized therapeutics test menu
50+
years of research in pharmacogenomics
25M
tests performed
annually
24/7
support from Mayo Clinic physicians and scientists
An individualized approach
When PGx is incorporated into clinical practice, drug selection is enhanced with the genetic profile of individual patients, improving the clinician’s ability to avoid adverse drug reactions and maximize therapeutic efficacy.
Differences that matter
We understand that interpreting testing results can be tricky, so we provide health care providers with customized clinical guidance based on testing results.
Access to Mayo Clinic expertise
When you partner with Mayo Clinic Laboratories, you extend your network to include some of
the world’s leading genetic experts. Mayo Clinic clinicians, laboratorians, and genetic counselors are available to discuss testing options, interpret
results, or help with case review and coordination
Pain Managment Testing in the Opioid Crisis and Beyond
In this “Virtual Lecture,” Christine Snozek, Ph.D., discusses the opioid epidemic as it relates to pain management along with what changes have been made regarding regulations and laboratory support.
Learn more about our therapeutics testing.
The Latest
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., will highlight Mayo Clinic’s new targeted benzodiazepine assay and discuss the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine compliance to benzodiazepine therapy.
Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be taken due to the results of this testing.
PACE / State of CA / State of FL
This “Phlebotomy” webinar reviews: Having a medical procedure or a lab draw can be fearful for children. Even if it is their first time or they have had a bad past experience, there are ways to make these procedures easier for children.
How Your Genes Determine which Medications Work Best for You
The drugs available today to treat diseases are powerful agents that work as intended for [...]